Let’s have a closer look at Gilead Sciences Inc (NASDAQ: GILD) and Moderna Inc (NASDAQ: MRNA) stocks as the companies are working on possible coronavirus vaccine.In the race for a coronavirus vaccine, two horses battle for the lead, Gilead Sciences Inc (NASDAQ: GILD) and Moderna Inc (NASDAQ: MRNA). As a result, a lot of speculation on the booming of their stock prices has been in the mainstream media, since the outbreak of the deadly virus.Gilead Sciences is an American public biotech company...
Read More »Gilead Sciences (GILD) Stock Surges after Launching Phase 3 Studies for Coronavirus Treatment
Gilead Sciences (GILD) stock surged and reached an all-time high after the company confirmed the launching of phase 3 studies of coronavirus treatment.Gilead Sciences Inc (NASDAQ: GILD), an American biotech company that specializes in researching, developing and commercializing drugs, has seen its stock surge after it announced the launching of phase 3 studies for naval coronavirus (COVID-19) treatment. The stock price broke a very critical resistant level at $68 to trade above $70.Amid the...
Read More »